| View |
|
DRP-12214-01
|
Fluconazole
|
Amflukonz
|
150 mg
|
Capsule
|
Antifungal
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
13 September 2023
|
12 August 2027
|
| View |
|
DRP-12306-01
|
Ceftriaxone (as sodium)
|
Cefriwind
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (third-generation cephalosporin)
|
Kilitch Drugs (India) Ltd
|
India
|
CLIDP Conversion
|
10 October 2023
|
12 July 2027
|
| View |
|
DRP-12306-02
|
Ceftriaxone (as sodium)
|
Tricexone
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (third-generation cephalosporin)
|
Kilitch Drugs (India) Ltd
|
India
|
CLIDP Conversion
|
03 October 2023
|
12 July 2027
|
| View |
|
DRP-12328-02
|
Metformin hydrochloride + Sitagliptin (as phosphate)
|
Sitaform 1/50
|
1 g/50 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
28 September 2023
|
15 July 2027
|
| View |
|
DRP-12349-01
|
Finasteride
|
Finpros
|
5 mg
|
Film Coated Tablet
|
Testosterone-5-alpha reductase inhibitor
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
11 September 2023
|
22 July 2027
|
| View |
|
DRP-12462-01
|
Quetiapine (as fumarate)
|
Emtaq 300
|
300 mg
|
Film-Coated Tablet
|
Antipsychotic
|
Hetero Labs Limited (Unit V)
|
India
|
CLIDP Conversion
|
10 October 2023
|
11 August 2027
|
| View |
|
DRP-12494-03
|
Clonidine hydrochloride
|
Chlonbitech
|
150 mcg
|
Tablet
|
Antihypertensive (Imidazoline Receptor Agonist)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
11 October 2023
|
19 August 2027
|
| View |
|
DRP-12495-01
|
Clonidine hydrochloride
|
Clodroxine
|
75 mcg
|
Tablet
|
Antihypertensive (Imidazoline Receptor Agonist)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
12 October 2023
|
19 August 2027
|
| View |
|
DRP-1225-07
|
Cefalexin (as Monohydrate)
|
Canexil
|
100 mg / mL
|
Powder for Suspension
|
Antibacterial (Cephalosporin)
|
LifeSquare Laboratories, Inc
|
Philippines
|
Renewal
|
25 September 2024
|
19 January 2030
|
| View |
|
DRP-12575-01
|
Ursodeoxycholic Acid
|
Ursostar 250
|
250 mg
|
Film-Coated Tablet
|
Bile and Liver Therapy (Bile acids and derivative)
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
27 September 2023
|
06 September 2027
|
| View |
|
DRP-12580-01
|
Cefuroxime (as axetil)
|
Zocef Kids
|
250 mg/5 mL
|
Powder for Oral Suspension
|
Antibacterial (Cephalosporin)
|
Hiral Labs Limited
|
India
|
CLIDP Conversion
|
10 October 2023
|
07 September 2027
|
| View |
|
DRP-12671-03
|
Ketorolac trometamol
|
Trialoc
|
30 mg/mL
|
Solution for Injection (I.M./I.V.)
|
Non-Steroidal Anti-inflammatory and Anti-rheumatic Product (Acetic Acid Derivative)
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
08 October 2023
|
21 September 2027
|
| View |
|
DRP-12735-01
|
Telmisartan + Amlodipine (as besilate)
|
Amplify 80/10
|
80mg/10mg
|
Tablet
|
Angiotensin II Receptor Blocker / Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
11 September 2023
|
30 September 2027
|
| View |
|
DRP-12735-02
|
Telmisartan + Amlodipine (as besilate)
|
Telmal
|
80 mg / 10 mg
|
Tablet
|
Angiotensin II Receptor Blocker / Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
06 October 2023
|
30 September 2027
|
| View |
|
DRP-12736-02
|
Telmisartan + Amlodipine (as besilate)
|
Amplify 40/10
|
40mg/10mg
|
Tablet
|
Angiotensin II Receptor Blocker / Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
15 September 2023
|
30 September 2027
|
| View |
|
DRP-12736-03
|
Telmisartan + Amlodipine (as besilate)
|
Telmal
|
40mg/10mg
|
Tablet
|
Angiotensin II Receptor Blocker / Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
28 September 2023
|
30 September 2027
|
| View |
|
DRP-12738-01
|
Telmisartan + Amlodipine (as besilate)
|
Amplify 40/5
|
40mg / 5mg
|
Tablet
|
Angiotensin II Receptor Blocker / Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
11 September 2023
|
30 September 2027
|
| View |
|
DRP-12738-02
|
Telmisartan + Amlodipine (as besilate)
|
Telmal
|
40 mg / 5 mg
|
Tablet
|
Angiotensin II Receptor Blocker / Calcium Channel Blocker
|
Evertogen Life Sciences Limited
|
India
|
CLIDP Conversion
|
08 October 2023
|
30 September 2027
|
| View |
|
DRP-12864-01
|
Glimepiride
|
Goperide
|
2 mg
|
Tablet
|
Oral Hypoglycemic Agent
|
Ratnatris Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
11 September 2023
|
18 October 2027
|
| View |
|
DRP-12894-01
|
Gliclazide
|
None
|
80 mg
|
Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
11 September 2023
|
25 January 2027
|